Concepedia

Publication | Open Access

Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)

DOIFull Paper Access

11

Citations

36

References

2019

Year

Annette F. Okai, Lilyana Amezcua, Regina Berkovich, Ángel Chinea, Keith R. Edwards, Brian Steingo, Aljoeson Walker, Alice K. Jacobs, Nadia Daizadeh, Mitzi Williams
Neurology and Therapy

Abstract

Sanofi (Cambridge, MA, USA) and Bayer HealthCare Pharmaceuticals (Leverkusen, Germany).

References

YearCitations

Page 1